What is an appropriate treatment plan for a 68-year-old white female with attention-deficit/hyperactivity disorder who is being started on stimulant medication?

Treatment Plan for 68-Year-Old Female with ADHD Starting Stimulant Medication

Start with methylphenidate 5 mg or amphetamine/dextroamphetamine 2.5 mg given twice daily (morning and noon), with mandatory cardiovascular screening before initiation and close monitoring for side effects given her age. 1

Pre-Treatment Assessment

Before prescribing stimulants, obtain:

• Baseline vital signs: Blood pressure, pulse, height, and weight 1
• Physical examination focusing on:
  • Cardiovascular status (symptomatic cardiovascular disease is a contraindication) 1
  • Blood pressure (hypertension is a contraindication) 1
  • Signs of hyperthyroidism or glaucoma (both contraindications) 1
• Medication history: Document any MAO inhibitor use (absolute contraindication) 1
• Psychiatric screening: Rule out active psychosis (contraindication) 1
• Substance use history: Assess patient and household members for stimulant abuse risk 1

Critical caveat for older adults: While the guidelines are based primarily on younger populations, research indicates that adults ≥50 years may experience more side effects and somatic complications, particularly after age 65 2. Physical assessment should be especially thorough in this age group.

Medication Initiation and Titration

Starting Dose

• Methylphenidate (MPH): 5 mg twice daily (after breakfast and lunch) 1
• OR Amphetamine/Dextroamphetamine (AMP/DEX): 2.5 mg once or twice daily 1

Titration Schedule

Week	MPH Dose	AMP/DEX Dose	Contact Method	Assessments
Baseline	-	-	Office visit	BP, pulse, weight, ADHD rating scale, side effects
1	5 mg BID	2.5 mg daily	Office visit	ADHD rating scale, side effects
2	10 mg BID	5 mg daily	Office or phone	ADHD rating scale, side effects
3-4	15 mg BID	7.5 mg daily	Office or phone	ADHD rating scale, side effects
4-5	20 mg BID	10 mg daily	Office visit	Full reassessment including vitals

1

For this 68-year-old patient specifically: Start at the lower end and titrate more slowly than you would for younger adults. Consider weekly increases of only 2.5-5 mg rather than the standard increments 2. The guideline recommendation to "titrate with low doses initially and with a slow increase" is particularly important here.

Monitoring Strategy

Symptom Assessment

• Use standardized ADHD rating scales (e.g., Conners Adult ADHD Rating Scale, Brown Attention-Deficit Disorder Scale for Adults) 1
• Collect ratings from both patient and a significant other if available 1
• Can obtain ratings via phone contact between visits 1
• Stop titration when symptoms resolve and impairment diminishes, not when reaching an arbitrary dose 1

Side Effect Monitoring

Monitor specifically for:

• Appetite suppression: Give medication with meals; offer high-calorie snacks in evening when medication wears off 1
• Insomnia: Lower the last dose or move it earlier in the day; distinguish from oppositional behavior 1
• Cardiovascular effects: Check BP and pulse quarterly (more frequently than the annual checks recommended for children) 1, 2
• Mood changes/sadness: May indicate need to reduce dose or switch to sustained-release formulation 1
• Irritability: Assess timing (peak effect vs. rebound); adjust dose accordingly 1

Long-term Monitoring

• Quarterly visits with BP and pulse checks 1
• Weight monitoring at each visit 1
• Annual comprehensive reassessment 1

Dose Optimization

Maximum doses: Total daily MPH typically ranges 10-60 mg; adults may require up to similar doses as children, though some need higher 1. However, for this older adult, exercise caution and prioritize tolerability over reaching standard maximum doses 2.

Decision point: Stop increasing dose when:

1. Symptoms have adequately improved
2. Impairment is diminished
3. Side effects become problematic
4. Clinical judgment indicates optimal benefit achieved 1

Alternative Approaches

If stimulants are poorly tolerated or contraindicated:

• Atomoxetine is the primary non-stimulant alternative with demonstrated efficacy in adults 3
• Consider psychosocial interventions (cognitive behavioral therapy) alone or combined with medication 2, 4, 5

Important consideration: After age 65, the risk-benefit ratio may shift unfavorably for stimulants due to increased cardiovascular complications 2. Be prepared to pivot to non-pharmacological approaches or non-stimulant medications if side effects emerge.

Key Pitfalls to Avoid

1. Don't skip cardiovascular screening: Undiagnosed hypertension or cardiac disease is more common in this age group
2. Don't titrate too aggressively: Older adults require slower titration than younger patients 2
3. Don't ignore household substance abuse risk: Screen family members who may have access to medication 1
4. Don't continue escalating if side effects emerge: Reverse course immediately 1
5. Don't rely solely on subjective reports: Use validated rating scales to guide dosing decisions 1

Documentation Requirements

Document before starting treatment:

• Prior psychosocial treatments attempted
• Previous medication trials (names, doses, duration, response, side effects, compliance)
• Baseline physical examination findings
• Rationale for stimulant selection 1

This structured approach balances the established efficacy of stimulants across age ranges 6, 4 with the heightened caution needed for older adults 2, prioritizing safety while optimizing symptom control and quality of life.